相关实验视频
Updated: Jun 16, 2026

13:51
The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
15.9K
对从早期到后期发展阶段的生物技术制造工艺病毒清除的分析
Opeyemi O Ajayi1, Jackie L Cullinan2, Innara Basria2
1Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), Office of Product Quality Assessment III (OPQA III), Division of Product Quality Assessment XIV (DPQA XIV).
PDA journal of pharmaceutical science and technology
|April 29, 2025
概括
确保生物技术产品的病毒安全性需要在制造过程中进行强大的病毒清除. 数据显示,化学无活化有效地去除反病毒,而过可以去除帕维病毒,确保产品的安全性.
科学领域:
- 生物技术是生物技术.
- 制药制造业 制药制造业 制药制造业
- 病毒安全 病毒安全
背景情况:
- 哺乳动物细胞系用于生产生物技术产品,如单克隆抗体.
- 病毒污染构成重大安全风险,必须在整个产品开发过程中加以管理.
- 监管机构要求进行严格的病毒清除研究,以确保产品的安全.
研究的目的:
- 分析过程变化对生物技术药物产品病毒清除的影响.
- 根据监管机构提交的长期数据,更新对病毒清除的理解.
- 评估不同单位操作在去除病毒方面的有效性.
主要方法:
- 从FDA调查新药 (IND) 提交 (1986-2024) 的综合病毒清除数据库的分析.
- 评估与产品开发过程中的工艺变化相关的病毒清除数据.
- 对染色学步骤的病毒清除相互作用过程参数效应的研究.
主要成果:
- 通过化学无活化,对复原病毒进行一致和强大的去除.
- 通过病毒保留性过有效地去除parvoviruses.
- 染色学单元的操作提供了额外的病毒去除能力.
- 工艺和产品特定因素显著影响整体病毒清除有效性.
结论:
- 化学失活和病毒保留性过对于减轻病毒安全风险至关重要.
- 染色学在增强病毒去除方面发挥着至关重要的作用.
- 对工艺和产品属性的个案评估对于在哺乳动物细胞衍生产品中实现可靠的病毒清除至关重要.
更多相关视频
相关概念视频
Methods of Classification and Identification
Bacterial identification relies on a diverse array of techniques to classify and understand microorganisms, each tailored to uncover specific characteristics. Traditional morphological approaches, while still valuable, are limited for closely related or structurally simple organisms. Modern methods integrate biochemical, serological, genetic, and advanced molecular tools to achieve greater accuracy.Morphological and Biochemical TechniquesMorphological characteristics, such as cell shape and...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

